Get the Stockscreener App
2.52
5.00%
0.12
Collplant Biotechnologies Ltd stock is traded at $2.52, with a volume of 44,410.
It is up +5.00% in the last 24 hours and up +14.03% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$2.40
Open:
$2.4
24h Volume:
44,410
Relative Volume:
0.37
Market Cap:
$32.04M
Revenue:
$2.47M
Net Income/Loss:
$-13.87M
P/E Ratio:
-2.0656
EPS:
-1.22
Net Cash Flow:
$-12.42M
1W Performance:
-1.17%
1M Performance:
+14.03%
6M Performance:
-27.38%
1Y Performance:
-51.45%
1-Day Range:
$2.25
$2.53
1-Week Range:
$1.87
$2.79
52-Week Range:
$1.31
$5.45
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.52 | 33.82M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
CollPlant Biotechnologies: Q2 2025 Financial Results and Updates - TipRanks
CollPlant Biotechnologies Ltd. stock chart pattern explainedWeekly Profit Summary & Fast Exit and Entry Strategy Plans - Newser
CollPlant Biotechnologies Ltd. stock trend forecast2025 Trading Volume Trends & Daily Growth Stock Tips - Newser
CollPlant Biotechnologies (CLGN) Receives Consistent "Buy" Rating from Analyst | CLGN Stock News - GuruFocus
Collplant Biotechnologies Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
How moving averages guide CollPlant Biotechnologies Ltd. tradingPortfolio Performance Summary & Short-Term High Return Ideas - Newser
Is CollPlant Biotechnologies Ltd. still worth holding after the dip2025 Technical Overview & Real-Time Stock Movement Alerts - Newser
CollPlant Biotechnologies Earnings Preview: Analysts Expect $0.06 EPS on 2023-08-20 - AInvest
Price momentum metrics for CollPlant Biotechnologies Ltd. explainedPortfolio Update Report & Proven Capital Preservation Methods - Newser
What high frequency data says about CollPlant Biotechnologies Ltd.Index Update & Weekly Top Stock Performers List - Newser
What data driven models say about CollPlant Biotechnologies Ltd.’s futureMarket Sentiment Summary & Risk Controlled Stock Pick Alerts - Newser
Will CollPlant Biotechnologies Ltd. bounce back from current supportWeekly Investment Summary & High Conviction Buy Zone Alerts - Newser
Earnings To Watch: CollPlant Biotechnologies Ltd (CLGN) Reports Q2 2025 Result - Yahoo Finance
CollPlant Biotechnologies Ltd. recovery potential after sell offEarnings Growth Report & Low Risk Entry Point Guides - Newser
Why CollPlant Biotechnologies Ltd. is moving today2025 Market WrapUp & Daily Price Action Insights - Newser
Intraday pattern recognizer results for CollPlant Biotechnologies Ltd.2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
Collplant Biotechnologies Ltd expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Regression Model Predicts Rangebound Movement in CollPlant Biotechnologies Ltd.July 2025 Update & Low Risk Entry Point Tips - sundaytimes.kr
Trend analysis for CollPlant Biotechnologies Ltd. this weekWeekly Trend Summary & Technical Entry and Exit Alerts - Newser
Will breakout in CollPlant Biotechnologies Ltd. lead to full recovery2025 Technical Patterns & Technical Confirmation Alerts - Newser
Exit strategy if you’re trapped in CollPlant Biotechnologies Ltd.Quarterly Risk Review & Real-Time Volume Trigger Notifications - Newser
Using AI based signals to follow CollPlant Biotechnologies Ltd.Earnings Summary Report & Free Real-Time Market Sentiment Alerts - Newser
Using Python tools to backtest CollPlant Biotechnologies Ltd. strategiesQuarterly Trade Report & Expert Verified Stock Movement Alerts - Newser
What dividend growth rate does CollPlant Biotechnologies Ltd. offerQuarterly Market Review & Verified Entry Point Detection - classian.co.kr
Volume Surge May Signal Institutional Interest in CollPlant Biotechnologies Ltd.Insider Selling & Community Verified Watchlist Alerts - sundaytimes.kr
What makes CollPlant Biotechnologies Ltd. stock price move sharplyDividend Hike & High Accuracy Investment Signals - Newser
Evaluating CollPlant Biotechnologies Ltd. with trendline analysisWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - Newser
Can CollPlant Biotechnologies Ltd. recover in the next quarterMarket Risk Analysis & Weekly Watchlist of Top Performers - Newser
Does CollPlant Biotechnologies Ltd. show high probability of rebound2025 Bull vs Bear & Verified Entry Point Detection - Newser
What does recent volatility data suggest for CollPlant Biotechnologies Ltd.2025 Market Sentiment & AI Optimized Trade Strategies - Newser
Will a bounce in CollPlant Biotechnologies Ltd. offer an exitJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
Using fundamentals and technicals on CollPlant Biotechnologies Ltd.Market Activity Recap & Community Verified Watchlist Alerts - Newser
Why CollPlant Biotechnologies Ltd. stock attracts strong analyst attention2025 Stock Rankings & Consistent Return Investment Signals - 선데이타임즈
CollPlant Biotechnologies (CLGN) to Release Earnings on Wednesday - Defense World
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):